RayzeBio Inc. Common Stoc...

NASDAQ: RYZB · Real-Time Price · USD
62.49
0.01 (0.02%)
At close: Feb 23, 2024, 10:00 PM

RayzeBio Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-68.6M -29.44M
Depreciation & Amortization
1.53M 455K
Stock-Based Compensation
6.33M 1.99M
Other Working Capital
2.52M 1.29M
Other Non-Cash Items
6.9M -6.85M
Deferred Income Tax
-351K 1.43M
Change in Working Capital
2.52M 1.29M
Operating Cash Flow
-51.68M -31.13M
Capital Expenditures
-9.1M -5.6M
Cash Acquisitions
n/a n/a
Purchase of Investments
-146.97M -190.51M
Sales Maturities Of Investments
128.85M 43.39M
Other Investing Acitivies
n/a -18.69M
Investing Cash Flow
-27.21M -171.4M
Debt Repayment
n/a n/a
Common Stock Repurchased
-1.91M -22K
Dividend Paid
n/a n/a
Other Financial Acitivies
157.54M 109.52M
Financial Cash Flow
157.54M 109.52M
Net Cash Flow
78.65M -93.01M
Free Cash Flow
-60.78M -36.72M